AC Immune
ACIU
42 hedge funds and large institutions have $137M invested in AC Immune in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
2% less capital invested
Capital invested by funds: $139M → $137M (-$2.16M)
1.49% less ownership
Funds ownership: 29.86% → 28.37% (-1.5%)
16% less funds holding
Funds holding: 50 → 42 (-8)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.19M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$858K |
| 3 |
Renaissance Technologies
New York
|
+$790K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$760K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$579K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QI
QS Investors
New York
|
-$854K |
| 2 |
PC
PA Capital
Richmond,
Virginia
|
-$507K |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$370K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$345K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$297K |
ACIU Hedge Fund Activity: Q2 2020 in Review
42 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2020, worth a combined $137M — down 1.5% from $139M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ACIU and 4 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 17 added.
The largest buyer was BlackRock, adding an estimated $1.19M. The largest seller was QS Investors, exiting entirely with an estimated $854K sold.
- 42 institutional investors held AC Immune (ACIU) as of Q2 2020, down from 50 in Q1 2020.
- Funds reported $137M of AC Immune stock for Q2 2020, down 1.5% quarter-over-quarter.
- 4 funds opened new AC Immune positions in Q2 2020 and 12 closed out, a net change of -8 holders.
- The largest AC Immune buyer in Q2 2020 was BlackRock, an estimated $1.19M added.
- The largest AC Immune seller in Q2 2020 was QS Investors, an estimated $854K sold.
Based on aggregated 13F filings for Q2 2020.